STOCK TITAN
  1. Home
  2. News
  3. EIGR

Eiger BioPharmaceuticals (EIGR) Stock News

EIGR Nasdaq
News

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-72.23%
Tags
none
-
News

Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.58%
Tags
none
-
News

Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.58%
Tags
stock split
News

Cutera Appoints Stephana Patton as Chief Legal Officer

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
management
-
News

Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.64%
Tags
earnings
-
News

Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-40.58%
Tags
clinical trial
News

Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
conferences
-
News

Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
earnings
-
News

Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.13%
Tags
none
News

Eiger BioPharmaceuticals to Host Business Update Call Tomorrow

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.13%
Tags
conferences